148 related articles for article (PubMed ID: 10968704)
1. Immunohistologic evaluation of metastatic carcinomas of unknown origin: an algorithmic approach.
DeYoung BR; Wick MR
Semin Diagn Pathol; 2000 Aug; 17(3):184-93. PubMed ID: 10968704
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical identification of carcinomas of unknown primary in serous effusions.
Pomjanski N; Grote HJ; Doganay P; Schmiemann V; Buckstegge B; Böcking A
Diagn Cytopathol; 2005 Nov; 33(5):309-15. PubMed ID: 16240395
[TBL] [Abstract][Full Text] [Related]
3. Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry.
Hsu FD; Nielsen TO; Alkushi A; Dupuis B; Huntsman D; Liu CL; van de Rijn M; Gilks CB
Mod Pathol; 2002 Dec; 15(12):1374-80. PubMed ID: 12481020
[TBL] [Abstract][Full Text] [Related]
4. Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm.
Dennis JL; Hvidsten TR; Wit EC; Komorowski J; Bell AK; Downie I; Mooney J; Verbeke C; Bellamy C; Keith WN; Oien KA
Clin Cancer Res; 2005 May; 11(10):3766-72. PubMed ID: 15897574
[TBL] [Abstract][Full Text] [Related]
5. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
6. Skin metastases from unknown origin: role of immunohistochemistry in the evaluation of cutaneous metastases of carcinoma of unknown origin.
Azoulay S; Adem C; Pelletier FL; Barete S; Francès C; Capron F
J Cutan Pathol; 2005 Sep; 32(8):561-6. PubMed ID: 16115055
[TBL] [Abstract][Full Text] [Related]
7. Glyco- and immunohistochemical refinement of the differential diagnosis between mesothelioma and metastatic carcinoma and survival analysis of patients.
Kayser K; Böhm G; Blum S; Beyer M; Zink S; André S; Gabius HJ
J Pathol; 2001 Feb; 193(2):175-80. PubMed ID: 11180163
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical panel of undifferentiated orbital metastatic carcinomas.
Godeiro KD; Odashiro AN; Odashiro DN; Fernandes BF; Burnier MN; Callejo S
Orbit; 2007 Jun; 26(2):101-6. PubMed ID: 17613856
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of monoclonal antibody B72.3 and gross cystic disease fluid protein-15 as markers of apocrine carcinoma of the breast.
Honma N; Takubo K; Arai T; Younes M; Kasumi F; Akiyama F; Sakamoto G
APMIS; 2006 Oct; 114(10):712-9. PubMed ID: 17004974
[TBL] [Abstract][Full Text] [Related]
10. Expression of cytokeratins and additional markers in undifferentiated lymph node metastases of the neck.
Bartel-Friedrich S; Friedrich RE; Holzhausen HJ
Anticancer Res; 2000; 20(6D):4931-40. PubMed ID: 11326642
[TBL] [Abstract][Full Text] [Related]
11. Recent immunohistochemical markers in the differential diagnosis of primary and metastatic carcinomas of the liver.
Gokden M; Shinde A
Diagn Cytopathol; 2005 Sep; 33(3):166-72. PubMed ID: 16078249
[TBL] [Abstract][Full Text] [Related]
12. Value of immunohistochemistry in confirming undifferentiated ovarian carcinomas.
Georgescu CV; Florescu M; Simionescu C
Rom J Morphol Embryol; 1999-2004; 45():133-42. PubMed ID: 15847387
[TBL] [Abstract][Full Text] [Related]
13. Practical Applications in Immunohistochemistry: Carcinomas of Unknown Primary Site.
Kandalaft PL; Gown AM
Arch Pathol Lab Med; 2016 Jun; 140(6):508-23. PubMed ID: 26457625
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody MOC-31 reactivity as a marker for adenocarcinoma in cytologic preparations.
Hecht JL; Pinkus JL; Pinkus GS
Cancer; 2006 Feb; 108(1):56-9. PubMed ID: 16329115
[TBL] [Abstract][Full Text] [Related]
15. Metastatic carcinoma of unknown primary: diagnostic approach using immunohistochemistry.
Conner JR; Hornick JL
Adv Anat Pathol; 2015 May; 22(3):149-67. PubMed ID: 25844674
[TBL] [Abstract][Full Text] [Related]
16. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
17. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.
Lau SK; Prakash S; Geller SA; Alsabeh R
Hum Pathol; 2002 Dec; 33(12):1175-81. PubMed ID: 12514785
[TBL] [Abstract][Full Text] [Related]
18. Anaplastic large-cell lymphoma with aberrant expression of multiple cytokeratins masquerading as metastatic carcinoma of unknown primary.
Nguyen TT; Kreisel FH; Frater JL; Bartlett NL
J Clin Oncol; 2013 Nov; 31(33):e443-5. PubMed ID: 23775969
[No Abstract] [Full Text] [Related]
19. Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas.
Kaufmann O; Fietze E; Mengs J; Dietel M
Am J Clin Pathol; 2001 Dec; 116(6):823-30. PubMed ID: 11764070
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical approaches to the diagnosis of undifferentiated malignant tumors.
Wick MR
Ann Diagn Pathol; 2008 Feb; 12(1):72-84. PubMed ID: 18164421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
